Verastem Oncology
VSTM
$10.90
Share price
5.21%
Change (1 day)
2,377.27%
Change (1 year)
Categories
EPS for Verastem Oncology (VSTM)
EPS in 2023 (TTM): -$4.37
According to Verastem Oncology 's latest financial reports the company's current EPS (TTM) is -$4.37. In 2022 the company made an earnings per share (EPS) of -$4.53 an increase over its 2021 EPS that were of -$4.92.
EPS history for Verastem Oncology from 2011 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$4.37 | -3.53% |
| 2022 | -$4.53 | -7.93% |
| 2021 | -$4.92 | -22.64% |
| 2020 | -$6.36 | -73.63% |
| 2019 | -$24.12 | 77.88% |
| 2018 | -$13.56 | -35.43% |
| 2017 | -$21.00 | 78.57% |
| 2016 | -$11.76 | -39.51% |
| 2015 | -$19.44 | -21.74% |
| 2014 | -$24.84 | 13.74% |
| 2013 | -$21.84 | 7.06% |
| 2012 | -$20.40 | -73.3% |
| 2011 | -$76.41 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $1.86 | -142.56% | 🇺🇸 USA |
 LabCorp LH | $7.52 | -272.08% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $3.50 | -180.11% | 🇬🇧 UK |
 Curis CRIS | -$10.00 | 128.83% | 🇺🇸 USA |